Alnylam Pharmaceuticals, Inc.

HSBC HOLDINGS PLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/6/2026

Shares

89,517

Value ($000)

35,675

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/6/2026	35,675	0.0%	89,517	12/31/2025
2025 Q3	11/13/2025	33,306	0.0%	73,014	9/30/2025
2025 Q2	8/13/2025	26,627	0.0%	81,748	6/30/2025
2025 Q1	5/14/2025	16,481	0.0%	61,265	3/31/2025
2024 Q4	2/14/2025	14,515	0.0%	61,582	12/31/2024
2024 Q3	11/14/2024	15,628	0.0%	56,870	9/30/2024
2024 Q2	8/12/2024	13,173	0.0%	54,155	6/30/2024
2024 Q1	5/15/2024	11,073	0.0%	74,131	3/31/2024
2023 Q4	2/12/2024	8,470	0.0%	44,199	12/31/2023
2023 Q3	11/13/2023	6,230	0.0%	35,185	9/30/2023
2023 Q2	8/11/2023	5,827	0.0%	30,677	6/30/2023
2023 Q1	5/15/2023	7,871	0.0%	39,294	3/31/2023
2022 Q4	2/14/2023	7,779	0.0%	32,734	12/31/2022
2022 Q3	11/14/2022	7,178	0.0%	35,393	9/30/2022
2022 Q2	8/11/2022	7,274	0.0%	49,861	6/30/2022
2022 Q1	5/16/2022	7,823	0.0%	47,827	3/31/2022
2021 Q4	2/11/2022	7,023	0.0%	41,340	12/31/2021
2021 Q3	11/12/2021	5,347	0.0%	28,714	9/30/2021
2021 Q2	8/13/2021	4,680	0.0%	27,710	6/30/2021
2021 Q1	5/14/2021	4,621	0.0%	32,920	3/31/2021
2020 Q4	2/25/2021	4,355	0.0%	33,490	12/31/2020
2020 Q3	11/12/2020	5,060	0.0%	34,675	9/30/2020
2020 Q2	8/14/2020	2,447	0.0%	16,521	6/30/2020
2020 Q1	5/15/2020	1,035	0.0%	9,509	3/31/2020
2019 Q4	2/14/2020	1,036	0.0%	8,883	12/31/2019